Arbutus BiopharmaABUS
那斯達克 · USD
4.64
+0.05
(+1.09%)
收盤 12/18 04:59 (UTC+8)
12/18 04:59 (UTC+8)
Arbutus BiopharmaABUS
4.64
+0.05
(+1.09%)
財務數據
損益表
- 0.05
- 0.05
- 0.02
- 0.02
- 0.02
- 0.01
- 0.02
- 0.02
- 0.11
- 0.01
- -30.45
- 0.15
- -53.95
- -28.58
- 12.66
- -22.42
- 17.55
- 12.07
- 508.79
- -95.07
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 529 | 10,739 | 1,764 | 1,574 | 1,339 | 1,726 | 1,532 | 2,145 | 4,658 | 4,651 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | 529 | 10,739 | 1,764 | 1,574 | 1,339 | 1,726 | 1,532 | 2,145 | 4,658 | 4,651 |
營業費用 | 9,188 | 9,251 | - | - | - | 23,309 | 20,895 | 22,892 | 26,216 | 23,036 |
研發費用 | 5,778 | 5,498 | 8,959 | 8,810 | 14,273 | 15,551 | 15,403 | 17,564 | 20,169 | 17,692 |
推銷及管理費用 | 3,312 | 3,588 | 6,131 | 6,602 | 4,881 | 7,758 | 5,492 | 5,328 | 6,047 | 5,344 |
非經常性項目費用 | 98 | 165 | 12,373 | 95 | 3,625 | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -8,659 | 1,488 | -25,699 | -13,933 | -21,440 | -21,583 | -19,363 | -20,747 | -21,558 | -18,385 |
其他收入及費用 | 940 | 1,063 | 1,201 | 1,431 | 1,752 | 1,821 | 1,532 | 1,479 | 1,500 | 1,462 |
利息費用 | 23 | 28 | 28 | 30 | 29 | 34 | 44 | 44 | 46 | 171 |
稅前純益 | -7,742 | 2,523 | -24,526 | -12,532 | -19,717 | -19,796 | -17,875 | -19,312 | -20,104 | -17,094 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -7,742 | 2,523 | -24,526 | -12,532 | -19,717 | -19,796 | -17,875 | -19,312 | -20,104 | -17,094 |
基本每股稅後盈餘(元) | -0.04 | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 | -0.10 | - | -0.12 | -0.10 |
稀釋每股稅後盈餘(元) | -0.04 | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 | -0.10 | -0.12 | -0.12 | -0.10 |
基本平均股數(千股) | 191778.00 | 191551.00 | 190707.00 | 189772.00 | 188997.00 | 188041.00 | 175625.00 | - | 167512.00 | 166063.00 |
稀釋平均股數(千股) | 191778.00 | 192399.00 | 190707.00 | 189772.00 | 188997.00 | 188041.00 | 175625.00 | - | 167512.00 | 166063.00 |
還原基本每股稅後盈餘(元) | -0.04 | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 | -0.10 | - | -0.12 | -0.10 |
還原稀釋每股稅後盈餘(元) | -0.04 | 0.01 | -0.13 | -0.07 | -0.10 | -0.11 | -0.10 | -0.12 | -0.12 | -0.10 |
還原基本平均股數(千股) | 191,778 | 191,551 | 190,707 | 189,772 | 188,997 | 188,041 | 175,625 | - | 167,512 | 166,063 |
還原稀釋平均股數(千股) | 191,778 | 192,399 | 190,707 | 189,772 | 188,997 | 188,041 | 175,625 | - | 167,512 | 166,063 |
EBITDA(千元) | -8,249 | 1,894 | -24,886 | -13,092 | -20,335 | -20,082 | -18,029 | -19,528 | -20,347 | -17,115 |